July 2020

COVID-19 and Cancer: NCI's Sharpless Says COVID-19 Could Halt Streak of US Cancer Mortality Gains

July 19, 2020

Evidence-Based Oncology

The talk by Ned Sharpless, MD, director of the National Cancer Institute, preceded presentations on some of the earliest findings about the effects of COVID-19 on cancer: It appears that patients treated with chemotherapy for lung or thoracic cancer shortly before being diagnosed with COVID-19 face a higher risk of death, and so do patients with cancer who take the combination of hydroxychloroquine (HCQ) and azithromycin.

Access to Care: Burris Says United With Our Patients, We Accelerate Progress Together

July 20, 2020

Evidence-Based Oncology

“We’ve had advancements, but we need to go faster,” said ASCO President Howard A. "Skip" Burris III, MD, as he stressed the importance of advancing therapies for better patient outcomes by addressing obstacles to patients’ care. “Access to care, access to clinical trials, and access to information are really key.”

Janssen's Wildgust Breaks Down Bispecific Antibodies in Development for Non-Small Cell Lung Cancer and Multiple Myeloma

July 22, 2020

Evidence-Based Oncology

During ASCO, Janssen presented results from the CHRYSALIS study on amivantimab, a bispecific antibody being developed to treat non–small cell lung cancer (NSCLC). The pharma giant, along with its parent company, Johnson & Johnson (J&J), had previously received a breakthrough therapy designation in December for teclistamab, another bispecific antibody indicated for potential treatment of multiple myeloma.

ASCO 2020: Genetic Testing

July 22, 2020

Evidence-Based Oncology

Four studies were highlighted that amplified the 3 components of using genetic testing in cancer treatment and prevention: (1) understanding the germline component of a tumor test, (2) broadening access to genetic counselors with video sessions, and (3) making sure risk assessment of each patient is accurate, so that patients do not have unnecessary surgeries.

ASCO 2020: AJMCtv Interviews

July 23, 2020

Evidence-Based Oncology

Interviews on presentations made during the 2020 Virtual meeting of the American Society of Clinical Oncology, featuring Drs Melissa L. Johnson, Constantine S. Tam, Adrian Kilcoyne, Sara L. Douglas, and Jeffrey Skolnick.